HOWL
Werewolf Therapeutics Inc

1,037
Mkt Cap
$44.89M
Volume
370,858.00
52W High
$2.38
52W Low
$0.595
PE Ratio
-0.57
HOWL Fundamentals
Price
$0.855
Prev Close
$0.9247
Open
$0.93
50D MA
$1.55
Beta
1.80
Avg. Volume
1.23M
EPS (Annual)
-$1.63
P/B
1.48
Rev/Employee
$40,978.26
Loading...
Loading...
News
all
press releases
Luke Evnin Sells 58,372 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 58,372 shares of the business's stock in a transaction that occurred on Thursday, November 13th. The stock was...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 26,101 Shares of Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 26,101 shares of the business's stock in a transaction on Wednesday, November 12th. The shares were sold at an...
MarketBeat·7d ago
News Placeholder
Luke Evnin Sells 31,172 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 31,172 shares of the firm's stock in a transaction dated Monday, November 10th. The stock was sold at an average...
MarketBeat·7d ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Director Luke Evnin Sells 35,818 Shares
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 35,818 shares of the stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of...
MarketBeat·7d ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Ansbert Gadicke Sells 40,669 Shares
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) major shareholder Ansbert Gadicke sold 40,669 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was...
MarketBeat·7d ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells $44,329.21 in Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) major shareholder Bioventures 2014 L.P. Mpm sold 40,669 shares of the stock in a transaction on Wednesday, November 12th. The stock was...
MarketBeat·7d ago
News Placeholder
Luke Evnin Sells 43,950 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 43,950 shares of the firm's stock in a transaction on Friday, November 7th. The stock was sold at an average price...
MarketBeat·7d ago
News Placeholder
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 48,570 Shares of Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) major shareholder Bioventures 2014 L.P. Mpm sold 48,570 shares of the business's stock in a transaction dated Monday, November 10th. The...
MarketBeat·7d ago
News Placeholder
Ansbert Gadicke Sells 48,570 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) major shareholder Ansbert Gadicke sold 48,570 shares of the firm's stock in a transaction dated Monday, November 10th. The shares were sold...
MarketBeat·7d ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells $63,623.40 in Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) major shareholder Ansbert Gadicke sold 55,810 shares of the company's stock in a transaction dated Tuesday, November 11th. The shares were...
MarketBeat·7d ago

Latest HOWL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.